ASX announcements
Appendix 4E Preliminary Final Report - 30 June 2020
18 August 2020
Appendix 4E Preliminary Final Report - 30 June 2020
Virtus Health Full Year Financial Results FY20 media release
18 August 2020
Virtus Health Full Year Financial Results FY20 media release
Notification of FY20 Full Year Results - Reporting Date and Investor Conference Call
12 August 2020
Notification of FY20 Full Year Results - Reporting Date and Investor Conference Call
Notification of release of restricted shares from escrow
28 May 2020
Virtus Health advises that a total of 68,305 fully paid ordinary shares currently held under voluntary escrow are due for release on 5 June 2020.
UBS Emerging Company Conference Presentation
21 May 2020
Virtus Health is presenting at the UBS Emerging Company Conference today and is pleased to disclose the management presentation
Virtus Health liquidity update
7 May 2020
Virtus Health is pleased to confirm it has amended its bank finance facilities through to 30 June 2021.
COVID-19 IMPACT UPDATE - Virtus Health resumes IVF treatment
21 April 2020
Virtus supports today’s decision by the Australian Federal Government to lift the suspension on elective surgery, including Assisted Reproductive Services
Notification of release of restricted shares from escrow
14 April 2020
Virtus Health advises that a total of 377,262 fully paid ordinary shares currently held under voluntary escrow are due for release as follows
COVID-19 update and interim dividend deferment
14 April 2020
Further to the market update on 25 March 2020, Virtus has undertaken a number of initiatives across the group in response to COVID-19
Federal Government private hospital viability for capacity guarantee
31 March 2020
ASX Virtus Health continue to engage with state health departments regarding its private hospital capacity to provide facilities and staff.
COVID-19 IMPACT UPDATE
25 March 2020
Virtus Health Limited (ASX “VRT”) provides the following update on the impact of COVID-19.
COVID_19 Impact
23 March 2020
Virtus Health Limited (ASX “VRT”) provides the following statement on the current impact of COVID-19.
Virtus Appoints Kate Munnings to Board of Directors
19 March 2020
Virtus Health ASX announcement - Virtus Appoints Kate Munnings to Board of Directors
Virtus Health financial results presentation H1 FY20
18 February 2020
Virtus Health financial results presentation H1 FY20
Appointment of New Group Chief Executive Officer
24 January 2020
Appointment of New Group Chief Executive Officer ASX announcement
Virtus Health Acquisition of SIMS IVF Shares
11 December 2019
Virtus Health Acquisition of SIMS IVF Shares